Production of germline transgenic Pacific salmonids with dramatically increased growth performance

Abstract

Transgenic Pacific salmon have been produced by microinjection of a DNA construct consisting of chinook salmon (Oncorhynchus tshawytscha) growth hormone sequences driven by an ocean pout (Macrozoarces americanus) antifreeze protein promoter. This construct was retained in approximately 4% of fish derived from injected eggs, and resulted in dramatic enhancement of growth relative to controls. For coho salmon (O. kisutch) at 15 months of age, the average size of transgenic fish was more than 10-fold that of controls, with the largest fish more than 30-fold larger than nontransgenic siblings. Dramatic growth enhancement was also observed in transgenic rainbow trout (O. mykiss), cutthroat trout (O. clarki), and chinook salmon using this same gene construct. Transgenic coho salmon underwent precocious parr–smolt transformation during their first fall, approximately 6 months in advance of their nontransgenic siblings. At 2 years of age, five male transgenic coho salmon became sexually mature, and four of these transmitted the gene construct to sperm, the negative fish being transgenic in blood but not fin tissue. These results show that while some fish are mosaic for the gene construct in different tissues, most are transgenic in both germline and somatic tissue.